Company / Cash per Share
aTYR PHARMA INC Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.13
FY2025
5-year range
$0.08 / $1.54
FY2021-FY2025
Trend
-26.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 7 years, ranging from $0.08 in FY2022 to $4.36 in FY2020.
Based on SEC 10-K filings.
0.13 in FY2025 with a 5-year CAGR of -50.6%.
Declined from $0.34 to $0.13 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +15.0%
- 5-Year CAGR
- -50.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 26.8% year-over-year.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | -26.8% |
| FY2024 | $0.17 | -48.4% |
| FY2023 | $0.34 | +302.6% |
| FY2022 | $0.08 | -94.5% |
| FY2021 | $1.54 | -64.7% |
| FY2020 | $4.36 | +3.4% |
| FY2019 | $4.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026